Avery Fairbank’s Post

🧠✨ Breaking New Ground in Neurological Research! A recent review article in the Alzheimer's Association journal sheds light on how COVID-19 and Alzheimer's disease-related dementia (ADRD) exhibit parallel electrophysiological abnormalities. Our very own Chief Scientific Officer, Dona Murphey MD PhD, reflects on her personal and professional journey with Neuro COVID and emphasizes the potential of EEG as a crucial biomarker in understanding and addressing cognitive changes in both Long COVID and ADRD. Discover more about the promising directions this research is taking in developing diagnostic and therapeutic tools. Read Dona’s full commentary here: https://lnkd.in/d5fUT4Yd 🔗 And don’t forget to check out the full article for a deeper dive into these groundbreaking findings: https://lnkd.in/eFpduMmd #SynthesysBrainHealth #NeuroCOVID #LongCOVID #AlzheimersResearch #EEGResearch #CognitiveHealth

The brain is a wondrous organ. With 86 billion neurons, it governs everything from our personality and emotions to our speech.   Neurological conditions, including brain disorders, are now the leading cause of illness and disability worldwide. When the brain encounters issues, the costs are staggering, both financial and human.   •The cost of mental health disorders alone is estimated to equal 5% of the world’s GDP and is projected to rise sharply towards 2030. •Neurological disorders alone account for 9 million deaths per year globally and are a primary driver of healthcare costs. •The WHO estimates the global economy loses about 1 trillion USD a year in productivity due to depression and anxiety alone.   These economic costs, as stunning as they are, tell only part of the story. The real bottom line is the ripple effects within families and communities and the greater societal impact that touches lives far beyond the numbers.   While I’m acutely aware that neuroscience research is complex, costly, and takes longer than most other types of scientific research, at Lundbeck, we are more committed than ever to advancing brain health by removing the barriers to neuroscience innovation and access to care.   For more than 70 years we have had the foresight and courage to maintain our focus on neuroscience. Our most important contribution to society is providing access to treatments that hold the potential to transform the lives of the millions of people living with brain diseases. And we are one of the few companies in the world that focus exclusively on these unmet needs.   We may never fully crack the code of the brain, but if we are to forge a future where healthcare truly serves the needs of all, the journey to discovery is worth taking.   #WorldBrainDay #Neuroscience #Innovation #BrainHealth

Understanding the differences between an Alzheimer's-affected brain and a healthy brain is critical to advancing treatment and support. Our latest blog dives into this stark contrast, exploring how Alzheimer's disease physically alters brain structures and impacts cognitive functions. 🔍 What do nerve cell tangles and amyloid plaques mean for Alzheimer's patients? 🧠 How does a shrinking hippocampus contribute to memory loss? Discover the science behind these changes and the promising research aimed at combating this devastating disease. Don't miss out on this eye-opening read! Read more: https://hubs.la/Q02RtRxx0 #AlzheimersResearch #BrainHealth #Neuroscience #HealthcareInnovation Claims regarding the effectiveness of EVY LIGHT® and 40 Hz light are based on ongoing research and have not been conclusively proven. EVY LIGHT® follows the published guidelines by FDA for low risk general wellness products and is not subject to FDA medical device regulations. EVY LIGHT® is not intended to diagnose, treat, cure, or prevent any diseases or medical conditions.

SPHERE Coaching - Vascular Risks Linked to Brain Health and Cognitive Decline A new study reveals that brain topological resilience (BTR) negatively correlates with age and vascular risk factors while positively correlating with cognitive function. Researchers analyzed data from two multi-ethnic cohorts, finding that lower BTR is associated with cognitive decline. This study suggests BTR as a significant marker for assessing brain health impacted by vascular risks and atherosclerosis. #BeAbrainOwner https://vist.ly/3b55g

Taking the bacteria from a human Alzheimer's patient and putting it into a young rat led to "cognitive deficits." More research on how the gut affects the brain. The more variety of fiber you eat the better your microbiome is and the healthier you are. Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis https://lnkd.in/etqHGNgA #microbiome #NeurologicalDisease #Alzheimers #gut #guthealth

🩺 Diagnosing Alzheimer's with Eye Movements 📰 Our latest newsletter dives into the latest research on Alzheimer's disease and dementia, featuring insights from clinical experts on the potential of eye-tracking technology in diagnosing these conditions. We explore two key questions:  ❓How eye-tracking can serve as a significant biomarker for early Alzheimer's diagnosis.  ❓How eye movements provide valuable clues for identifying specific types of dementia. 👩⚕️For those interested in this topic, don't miss the recording of Dr. Lejla Koric's presentation (AP-HM, neurology and neuropsychology, CHU de Timone) at our last clinical gathering. She discussed how eye-tracking prompted a reevaluation of a Mild Cognitive Impairment diagnosis, ultimately leading to a diagnosis of Posterior Cortical Atrophy (PCA). (link in comments)  🔔Stay updated with the latest research on eye movements and neurological disorders by subscribing to our newsletter! If you have insights to share, connect with us—we're always eager to learn more about the fascinating world of eye movements. #neuroscience #biomarkers #eyetracking  

💡 New research suggests that non-invasive gamma wave stimulation can treat neurological disorders, such as Alzheimer's disease. Low-range gamma waves produce around 40 oscillations per second and are crucial to the brain's memory processes. In a 2016 MIT study published in Nature, researchers found that using electrical or magnetic stimulation to enhance the gamma frequency in Alzheimer's patients, subsequently reduced the effects of the disease. “Research into the clinical potential of these interventions is still in its nascent stages,” the researchers wrote. “The precise mechanisms underpinning the beneficial effects of gamma stimulation in Alzheimer’s disease are not yet fully elucidated, but preclinical studies have provided relevant insights.” Read more: https://lnkd.in/e-cpFy9E #neuroscience #research #openbci #eeg #brainwaves

In this article by Katie Peek for Scientific American, which coincides with 'Brain Awareness Month' in June, the latest neuroscience sheds light on the origins and progression of Alzheimer's disease. Alzheimer’s wreaks havoc by annihilating neurons, the long-living cells of the brain, and disrupting communication among the surviving ones. As neurons perish, the brain regions they compose start to waste away. Though the exact picture of this deterioration is still being pieced together, researchers have observed a common pattern of brain atrophy in Alzheimer’s patients. This understanding holds promise for earlier diagnosis, potentially allowing interventions like medication and lifestyle adjustments to effectively slow the progression of dementia. Alzheimer's disease tends to unfold in a predictable manner, as observed through brain imaging and research. It begins by ravaging neurons and disrupting intercellular communication, leading to the atrophy of brain regions. Although the specifics of this process vary from person to person, a consistent pattern of brain degeneration emerges among those afflicted with Alzheimer's. This knowledge offers hope for the development of methods to detect the disease in its early stages, providing a window for effective treatment and lifestyle interventions to combat dementia. Katie Peek is a science journalist and data-visualization designer with degrees in astrophysics and journalism. Katie's article and the subsequent graphics in Scientific American were produced in partnership with the Davos Alzheimer's Collaborative. #Alzheimers #Neuroscience #BrainAwarenessMonth #ENDALZ #trustscience

ICYMI: For the first time, Prof. Alexander Opitz and team showed that non-invasive brain stimulation can change a specific brain mechanism that is directly related to human behavior. This is a major step forward for discovering new therapies to treat brain disorders such as schizophrenia, depression, Alzheimer’s disease, and Parkinson’s disease. Read more: https://bit.ly/3wTveBY University of Minnesota College of Science and Engineering University of Minnesota, Research & Innovation Office (RIO) #neuralengineering #neuroengineering #biomedicalengineering #bioengineering #alzheimers #schizophrenia #depression #parkinsons

Fascinating use of AI